Menu Back toSession-0402-Application-of-Bayesian-Methods-for-Clinical-Trials
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
The 7th DIA China Annual Meeting
Session 0402 Application of Bayesian Methods for Clinical Trials
- GSK, China
Maximizing Return on Investment in Designing Phase II Clinical Trials
Cong Chen, PhD
- Merck & Co., Inc., United States
A Bayesian prediction model between biomarker and clinical endpoint for dichotomous variables
- Sr. Prin. Scientist, Biostatistics
- MSD, China
A case study for a Bayesian approach to the assessment of safety for biosimilar and its application to bridging study (CN&EN)
- Pfizer, United States